Chongqing Taiji Industry (600129.SH): Metformin and Voglibose Hydrochloride Tablets () Obtained Drug Registration Certificate.

date
16:38 13/05/2026
avatar
GMT Eight
Taiji Pharmaceutical Group (600129.SH) announced that recently, its holding subsidiary, Southwest Pharmaceutical Co., Ltd. ("Southwest Pharmaceutical"), received the "Drug Registration Certificate" for the metformin and empagliflozin tablets (I) issued by the National Medical Products Administration. It is reported that this drug is suitable for type 2 diabetes adult patients who are currently receiving empagliflozin and metformin hydrochloride treatment, used to improve blood sugar control in these patients.
Chongqing Taiji Industry (600129.SH) announced that its controlling subsidiary Southwest Pharmaceutical Co., Ltd. ("Southwest Pharmaceutical") recently received the "Drug Registration Certificate" for Metformin Sitagliptin tablets (I) issued by the National Medical Products Administration. It is reported that this drug is suitable for type 2 diabetes adult patients who are currently undergoing treatment with sitagliptin and metformin hydrochloride, to improve their blood glucose control.